These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19389560)

  • 41. Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: observations from "Assessment of Pexelizumab in Acute Myocardial Infarction".
    French JK; Armstrong PW; Cohen E; Kleiman NS; O'Connor CM; Hellkamp AS; Stebbins A; Holmes DR; Hochman JS; Granger CB; Mahaffey KW
    Am Heart J; 2011 Jul; 162(1):89-97. PubMed ID: 21742094
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gender differences in long-term outcome after primary percutaneous intervention for ST-segment elevation myocardial infarction.
    Wijnbergen I; Tijssen J; van 't Veer M; Michels R; Pijls NH
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):379-84. PubMed ID: 23553888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
    Garg S; Sarno G; Serruys PW; Rodriguez AE; Bolognese L; Anselmi M; De Cesare N; Colangelo S; Moreno R; Gambetti S; Monti M; Bristot L; Bressers M; Garcia-Garcia HM; Parrinello G; Campo G; Valgimigli M;
    JACC Cardiovasc Interv; 2011 Jan; 4(1):66-75. PubMed ID: 21251631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transfer times and outcomes in patients with ST-segment-elevation myocardial infarction undergoing interhospital transfer for primary percutaneous coronary intervention: APEX-AMI insights.
    van Diepen S; Widimsky P; Lopes RD; White KR; Weaver WD; Van de Werf F; Ardissino D; van't Hof AW; Armstrong PW; Granger CB
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):437-44. PubMed ID: 22589297
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of ST-segment resolution after rescue percutaneous coronary intervention. Data from the RICO survey.
    Lorgis L; Zeller M; Dentan G; Laurent Y; Taam JA; L'Huillier I; Vincent-Martin M; Makki H; Cottin Y;
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):607-12. PubMed ID: 18360851
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term prognostic value of ST-segment resolution in patients treated with fibrinolysis or primary percutaneous coronary intervention results from the DANAMI-2 (DANish trial in acute myocardial infarction-2).
    Sejersten M; Valeur N; Grande P; Nielsen TT; Clemmensen P;
    J Am Coll Cardiol; 2009 Nov; 54(19):1763-9. PubMed ID: 19874989
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Significance of T-wave amplitude and dynamics at the time of reperfusion in patients with acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Sørensen JT; Murinson MA; Kaltoft AK; Nikus KC; Wagner GS; Terkelsen CJ
    J Electrocardiol; 2009; 42(6):677-83. PubMed ID: 19595361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients?
    Bainey KR; Fu Y; Granger CB; Hamm CW; Holmes DR; O'Neill WW; Seabra-Gomes R; Pfisterer ME; Van de Werf F; Armstrong PW;
    Heart; 2009 Aug; 95(16):1331-6. PubMed ID: 19447835
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diabetes mellitus is associated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty and glycoprotein IIb-IIIa inhibitors.
    De Luca G; Gibson CM; Bellandi F; Noc M; Dudek D; Zeymer U; Arntz HR; Cutlip D; Maioli M; Zorman S; Mesquita Gabriel H; Emre A; Rakowski T; Gyongyosi M; Huber K; Van't Hof AW
    Atherosclerosis; 2009 Nov; 207(1):181-5. PubMed ID: 19426981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Excimer laser in myocardial infarction: a comparison between STEMI patients with established Q-wave versus patients with non-STEMI (non-Q).
    ; Topaz O; Ebersole D; Dahm JB; Alderman EL; Madyoon H; Vora K; Baker JD; Hilton D; Das T
    Lasers Med Sci; 2008 Jan; 23(1):1-10. PubMed ID: 17426922
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adverse outcomes in fibrinolytic-based facilitated percutaneous coronary intervention: insights from the ASSENT-4 PCI electrocardiographic substudy.
    McDonald MA; Fu Y; Zeymer U; Wagner G; Goodman SG; Ross A; Granger CB; Van de Werf F; Armstrong PW;
    Eur Heart J; 2008 Apr; 29(7):871-9. PubMed ID: 18319519
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aborted myocardial infarction in ST-elevation myocardial infarction: insights from the STrategic Reperfusion Early After Myocardial infarction trial.
    Dianati Maleki N; Van de Werf F; Goldstein P; Adgey JA; Lambert Y; Sulimov V; Rosell-Ortiz F; Gershlick AH; Zheng Y; Westerhout CM; Armstrong PW
    Heart; 2014 Oct; 100(19):1543-9. PubMed ID: 24916050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcomes of a pharmacoinvasive strategy for successful versus failed fibrinolysis and primary percutaneous intervention in acute myocardial infarction (from the STrategic Reperfusion Early After Myocardial Infarction [STREAM] study).
    Welsh RC; Van de Werf F; Westerhout CM; Goldstein P; Gershlick AH; Wilcox RG; Danays T; Bluhmki E; Lopes RD; Steg PG; Armstrong PW
    Am J Cardiol; 2014 Sep; 114(6):811-9. PubMed ID: 25108302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention.
    Huczek Z; Kochman J; Filipiak KJ; Horszczaruk GJ; Grabowski M; Piatkowski R; Wilczynska J; Zielinski A; Meier B; Opolski G
    J Am Coll Cardiol; 2005 Jul; 46(2):284-90. PubMed ID: 16022956
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of prognostic value of epicardial blood flow and early ST-segment resolution after primary coronary angioplasty. ANIN--Myocardial Infarction Registry.
    Kalińczuk Ł; Przyłuski J; Karcz M; Petryka J; Kaczmarska E; Bekta P; Kepka C; Kruk M; Pregowski J; Kadziela J; Deptuch T; Skwarek M; Cedro K; Ciszewski M; Debski A; Ciszewski A; Chmielak Z; Demkow M; Witkowski A; Ruzyłło W
    Kardiol Pol; 2007 Jan; 65(1):1-10; discussion 11-2. PubMed ID: 17295155
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-throughput targeted proteomics discovery approach and spontaneous reperfusion in ST-segment elevation myocardial infarction.
    Shavadia JS; Granger CB; Alemayehu W; Westerhout CM; Povsic TJ; Brener SJ; van Diepen S; Defilippi C; Armstrong PW
    Am Heart J; 2020 Feb; 220():137-144. PubMed ID: 31812755
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial).
    Marso SP; Miller T; Rutherford BD; Gibbons RJ; Qureshi M; Kalynych A; Turco M; Schultheiss HP; Mehran R; Krucoff MW; Lansky AJ; Stone GW
    Am J Cardiol; 2007 Jul; 100(2):206-10. PubMed ID: 17631071
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amount of ST wave resolution in patients with and without spontaneous coronary reperfusion in the infarct -related artery after primary PCI: an observational study.
    Erden EC; Erden I; Türker Y; Aslantaş Y; Yalçın S; Karabacak A
    Anadolu Kardiyol Derg; 2012 Feb; 12(1):30-4. PubMed ID: 22214740
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial.
    Granger CB; Mahaffey KW; Weaver WD; Theroux P; Hochman JS; Filloon TG; Rollins S; Todaro TG; Nicolau JC; Ruzyllo W; Armstrong PW;
    Circulation; 2003 Sep; 108(10):1184-90. PubMed ID: 12925454
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study.
    Ali A; Cox D; Dib N; Brodie B; Berman D; Gupta N; Browne K; Iwaoka R; Azrin M; Stapleton D; Setum C; Popma J;
    J Am Coll Cardiol; 2006 Jul; 48(2):244-52. PubMed ID: 16843170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.